Experience

Fusion Genomics Corporation

• Canada
• Biotechnology Research
• 1 - 100 Employee

• Business Development and Regulatory Affairs Consultant

  • Oct 2014 - Present

  Fusion Genomics Corporation is a next-generation sequencing (NGS) based diagnostic assay development company focussing on tests for the detection of paediatric cancers (sarcomas), blood cancers (leukaemia, lymphoma and myeloma) and infectious disease (influenza, hepatitis, tuberculosis, leptospirosis). • Managing the scientific, financial, and regulatory activities associated with the development of NGS-based assays for infectious disease. In addition, acting as the main point of contact for scientific collaborators at British Columbia Centre for Disease Control and Royal Tropical Institute (Netherlands). • Refining Fusion Genomics’ strategic business plan, financial projections and funding strategy for the development of diagnostic assays. • Submitting applications for funding from public and private institutions. e.g.: Awarded funding from NRC-IRAP (2014-2015): Development of next-generation sequencing-based and bioinformatics technologies for rapid and accurate differential diagnosis of Mycobacterium tuberculosis and Leptospira pathogens. Show less



VSC Bio Consulting

• Vancouver, Canada Area

• Business Consultant

  • Sep 2012 - Present

  Developing strategic business plan and tax credit submission for an early-stage nutraceutical company based in British Columbia. Developing strategic business plan and tax credit submission for an early-stage nutraceutical company based in British Columbia.



BC Children's Hospital Research Institute & University of British Columbia

• Vancouver, British Columbia, Canada

• Director of Operations

  • Aug 2020 - Mar 2022

  • Worked with both the information technology team and the commercial service provider: BC Platforms to establish a data storage and analysis platform for 1) next-generation sequence data, 2) genome-wide association studies data, 3) targeted genotyping. • Provided research progress to the project leaders, group members and local and international collaborators. • Oversaw and worked with the project team members to accelerate the completion of project deliverables. Developed standard operating procedures for the various workflows, mentored trainees on their specific projects, and assisted in the identification and recruitment of new well qualified personnel. • Identified new research funding support opportunities from grant funding agencies including: CIHR, NMIN, Genome Canada, Genome British Columbia and others. In addition, worked with the senior research team towards the development of research programs for the identified funding competitions. Show less



Genome Canada Transplant Consortium

• Vancouver, Canada

• Precision Medicine Program Manager

  • Sep 2017 - Nov 2019

  Based in the Vancouver General Hospital, the Genome Canada Transplant Consortium is an international program employing Precision Medicine strategies and advanced genomic, immunologic and pharmacologic technologies in organ transplantation. • Helped to secure Government and Industry funding ($10.8 M) by generating the financial documentation and aiding in the writing of a proposal entitled: Precision Medicine CanPREVENT AMR: Applying Precision Medicine Technologies in Canada to Prevent Antibody Mediated Rejection and Premature Kidney Transplant Loss. The aims of the program are to: 1. Improve donor matching through DNA-based epitope typing 2. Identify risk of rejection through immune monitoring 3. Develop personalized treatment through systems pharmacology 4. Inform health policy decisions through social, legal and economic data • Overseeing the coordination of research activities for over 70 researchers and clinicians located in Canada, United States and the European Union. My activities include development of research agreements, allocation and distribution of funds to project members, identification and recruitment of highly qualified personnel, collection and dissemination of the project’s scientific and financial progress. Show less



Genome British Columbia

• Canada
• Biotechnology Research
• 1 - 100 Employee

• Research Program Manager

  • Mar 2013 - Sep 2014

  • Launched and monitored 15 small and 7 large-scale genomics and proteomics research and development projects • Monitored, reported and liaised with 4 large multi-million dollar international project regarding project milestones, financial reporting, novel and significant developments, and regulatory and intellectual property issues. • Launched and monitored 15 small and 7 large-scale genomics and proteomics research and development projects • Monitored, reported and liaised with 4 large multi-million dollar international project regarding project milestones, financial reporting, novel and significant developments, and regulatory and intellectual property issues.



Genome British Columbia

• Vancouver

• Research Program Manager

  • Jul 2010 - Jul 2012

  Managed a portfolio of 12 genomics and proteomics-related research programs with a total value of over $25M. • Monitored 5 large-scale and 7 smaller-scale projects regarding project milestones, financial reporting, and regulatory and intellectual property issues. Managed a portfolio of 12 genomics and proteomics-related research programs with a total value of over $25M. • Monitored 5 large-scale and 7 smaller-scale projects regarding project milestones, financial reporting, and regulatory and intellectual property issues.



MITACS

• Vancouver

• Internship Proposal Reviewer

  • Apr 2010 - Apr 2011

  • Evaluated or coordinated the evaluation of research proposals in a variety of fields including health research, geography, oceanography, ecology and engineering. • Evaluated or coordinated the evaluation of research proposals in a variety of fields including health research, geography, oceanography, ecology and engineering.



BC Mental Health and Substance Use Services

• Canada
• Hospitals and Health Care
• 1 - 100 Employee

• Research Associate

  • Apr 2009 - Jun 2010

  • Identified changes in myelin proteins levels in Schizophrenia by comparing diagnosed patients with unaffected individuals. • Identified changes in myelin proteins levels in Schizophrenia by comparing diagnosed patients with unaffected individuals.



Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency

• Vancouver, Canada Area

• Postdoctoral Fellow

  • Sep 2004 - Dec 2008

  • Conceptualized and developed a potential therapy for Huntington Disease by generating a novel viral–based gene methodology. • Identified and published a database of genes with brain region-specific gene expression by effectively integrating bioinformatics approaches, chairing gene-choosing meetings, and writing progress reports and scientific manuscripts. • Generated new potential sources of research and university revenues by filing three provisional patents. • Identified novel sequence variations in the 40Kb intergenic region of the GABA receptor α4 and β1 subunit genes in Premenstrual Dysphoric Disorder patients and unaffected family members by exploiting high-throughput sequencing and data analysis technologies. • Identified DNA copy number variations in Bipolar Disorder and Schizophrenia using Affymetrix and BAC microarray technologies. • Developed a new copy number variation methodology by creating a novel bacterial artificial chromosome (BAC) microarray spotting approach. Show less